Medicilon has constructed the GMP Drug Products Pilot Plant to meet the rising needs for innovative medicine R&D, production, packaging, inspections and stability tests. We offer qualified CDMO services for clients with requirements for the development of innovative medicine.
CDMO Service Platform
Medicilon’s Preparation workshop
World's First Inhaled Nanobody Drug LQ036
Congratulations on the positive phase I clinical results of Raymon Pharma's first Chinese eye drops for the treatment of wAMD
Medicilon assists HitGen's HG381 to be approved as China's first clinical STING agonist